Healthcare Sector Stocks
The Healthcare sector has a total of 1046 stocks, with a combined market cap of $9.05 trillion, total revenue of $4.67 trillion and a weighted average PE ratio of 47.32.
Market Cap
9.05T
Revenue
4.67T
Profits
191.22B
PE Ratio
47.32
Profit Margin
4.10%
Dividend Yield
0.39%
1046 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.02T | -0.24% | 1,067,006 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 615.57B | -1.25% | 4,380,022 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 464.51B | 1.13% | 2,916,509 | 64.39B |
| 4 | MRK | Merck & Co., Inc. | 354.98B | 0.05% | 3,820,672 | 66.57B |
| 5 | UNH | UnitedHealth Group Incorporated | 331.50B | 1.13% | 1,764,834 | 450.53B |
| 6 | NVS | Novartis AG | 270.16B | -0.33% | 1,611,817 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 246.55B | -0.44% | 1,703,300 | 61.37B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 241.83B | 0.23% | 1,053,005 | 46.34B |
| 9 | AMGN | Amgen Inc. | 218.50B | -0.76% | 1,256,667 | 38.10B |
| 10 | GILD | Gilead Sciences, Inc. | 179.02B | -2.12% | 2,170,942 | 30.46B |
| 11 | ABT | Abbott Laboratories | 168.30B | 0.59% | 4,818,630 | 46.59B |
| 12 | NVO | Novo Nordisk A/S | 165.74B | -0.27% | 7,724,503 | 50.34B |
| 13 | PFE | Pfizer Inc. | 157.97B | -1.44% | 21,089,668 | 63.70B |
| 14 | DHR | Danaher Corporation | 151.52B | 1.79% | 2,144,738 | 25.11B |
| 15 | ISRG | Intuitive Surgical, Inc. | 138.61B | -2.22% | 1,072,864 | 11.03B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 127.83B | -0.48% | 463,357 | 12.59B |
| 17 | BMY | Bristol-Myers Squibb Company | 123.95B | -0.25% | 4,069,648 | 49.19B |
| 18 | MDT | Medtronic plc | 110.47B | -0.09% | 25,283,589 | 37.54B |
| 19 | CVS | CVS Health Corporation | 109.91B | 0.87% | 5,773,685 | 412.65B |
| 20 | SYK | Stryker Corporation | 105.61B | 0.86% | 1,053,288 | 25.84B |
| 21 | MCK | McKesson Corporation | 103.56B | -1.17% | 396,974 | 410.98B |
| 22 | SNY | Sanofi | 98.60B | -1.88% | 3,381,185 | 55.89B |
| 23 | GSK | GSK plc | 95.02B | -0.08% | 3,631,399 | 44.05B |
| 24 | HCA | HCA Healthcare, Inc. | 92.16B | 0.55% | 483,446 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 83.71B | 1.14% | 446,842 | 201.11B |
| 26 | MRNA | Moderna, Inc. | 75.28B | -0.20% | 8,276,984 | 2.23B |
| 27 | REGN | Regeneron Pharmaceuticals, Inc. | 73.43B | 0.07% | 318,642 | 15.53B |
| 28 | CI | The Cigna Group | 70.82B | 0.02% | 988,059 | 282.38B |
| 29 | BSX | Boston Scientific Corporation | 62.11B | -0.87% | 11,989,901 | 21.00B |
| 30 | ARGX | argenx SE | 59.26B | -2.03% | 266,423 | 5.32B |
| 31 | COR | Cencora, Inc. | 58.85B | -0.45% | 644,292 | 332.77B |
| 32 | NTRA | Natera, Inc. | 58.79B | -0.15% | 1,309,711 | 2.71B |
| 33 | TAK | Takeda Pharmaceutical Company Limited | 57.21B | 0.06% | 1,618,717 | 28.42B |
| 34 | CAH | Cardinal Health, Inc. | 52.74B | -1.00% | 581,733 | 254.25B |
| 35 | EW | Edwards Lifesciences Corporation | 49.30B | 0.40% | 1,122,192 | 6.51B |
| 36 | BDX | Becton, Dickinson and Company | 48.11B | -0.82% | 782,716 | 22.48B |
| 37 | A | Agilent Technologies, Inc. | 47.28B | 0.61% | 1,215,995 | 7.37B |
| 38 | MDLN | Medline Inc. | 46.61B | 1.46% | 6,604,225 | 29.94B |
| 39 | HUM | Humana Inc. | 46.11B | 1.14% | 325,627 | 145.68B |
| 40 | TEVA | Teva Pharmaceutical Industries Limited | 46.08B | 0.59% | 3,142,922 | 17.32B |
| 41 | VEEV | Veeva Systems Inc. | 44.29B | -2.98% | 633,026 | 3.46B |
| 42 | RVMD | Revolution Medicines, Inc. | 44.14B | 0.03% | 1,020,219 | - |
| 43 | IQV | IQVIA Holdings Inc. | 42.53B | -0.90% | 673,312 | 16.98B |
| 44 | WAT | Waters Corporation | 41.91B | 0.25% | 339,722 | 4.64B |
| 45 | IDXX | IDEXX Laboratories, Inc. | 41.00B | 0.52% | 128,712 | 4.55B |
| 46 | ILMN | Illumina, Inc. | 40.88B | 1.87% | 1,588,170 | 4.49B |
| 47 | ONC | BeOne Medicines AG | 40.23B | -1.38% | 237,172 | 6.13B |
| 48 | HLN | Haleon plc | 38.26B | 0.86% | 17,545,520 | 14.80B |
| 49 | RPRX | Royalty Pharma plc | 32.90B | -0.71% | 1,205,055 | 2.54B |
| 50 | BIIB | Biogen Inc. | 32.62B | -0.91% | 443,006 | 10.03B |
| 51 | DXCM | DexCom, Inc. | 32.12B | -1.28% | 1,289,846 | 4.97B |
| 52 | RMD | ResMed Inc. | 31.37B | -0.85% | 343,615 | 5.65B |
| 53 | CNC | Centene Corporation | 31.06B | 3.10% | 1,704,296 | 180.30B |
| 54 | ALC | Alcon Inc. | 30.80B | -0.47% | 775,145 | 10.86B |
| 55 | MTD | Mettler-Toledo International Inc. | 29.85B | 0.57% | 69,925 | 4.13B |
| 56 | ALNY | Alnylam Pharmaceuticals, Inc. | 29.73B | -3.90% | 955,894 | 4.80B |
| 57 | GEHC | GE HealthCare Technologies Inc. | 29.12B | 0.75% | 1,326,348 | 21.27B |
| 58 | ZTS | Zoetis Inc. | 28.90B | 1.22% | 3,198,616 | 9.53B |
| 59 | ROIV | Roivant Sciences Ltd. | 25.76B | 0.45% | 2,460,607 | 7.53M |
| 60 | WST | West Pharmaceutical Services, Inc. | 25.70B | 0.05% | 248,571 | 3.33B |
| 61 | DGX | Quest Diagnostics Incorporated | 25.54B | 0.13% | 623,531 | 11.56B |
| 62 | LH | Labcorp Holdings Inc. | 24.87B | 0.66% | 298,582 | 14.35B |
| 63 | BNTX | BioNTech SE | 24.23B | -0.39% | 471,861 | 3.03B |
| 64 | INSM | Insmed Incorporated | 24.03B | 1.33% | 2,843,488 | 1.14B |
| 65 | GH | Guardant Health, Inc. | 23.85B | 1.71% | 1,092,263 | 1.18B |
| 66 | UTHR | United Therapeutics Corporation | 23.34B | -4.74% | 578,369 | 3.15B |
| 67 | PHG | Koninklijke Philips N.V. | 23.33B | 0.40% | 572,171 | 20.18B |
| 68 | INCY | Incyte Corporation | 23.32B | -1.78% | 972,762 | 5.82B |
| 69 | GMAB | Genmab A/S | 20.81B | -0.03% | 4,091,177 | 4.13B |
| 70 | THC | Tenet Healthcare Corporation | 20.78B | 1.60% | 276,462 | 21.81B |
| 71 | STE | STERIS plc | 20.26B | -0.75% | 313,677 | 6.04B |
| 72 | VTRS | Viatris Inc. | 20.20B | 0.72% | 4,404,687 | 14.74B |
| 73 | RVTY | Revvity, Inc. | 16.89B | 1.53% | 717,586 | 2.91B |
| 74 | ZBH | Zimmer Biomet Holdings, Inc. | 16.77B | -0.15% | 824,427 | 8.51B |
| 75 | MEDP | Medpace Holdings, Inc. | 16.74B | 0.28% | 182,955 | 2.78B |
| 76 | JAZZ | Jazz Pharmaceuticals plc | 15.41B | 1.91% | 275,874 | 4.60B |
| 77 | SOLV | Solventum Corporation | 15.06B | 0.80% | 348,576 | 8.31B |
| 78 | ASND | Ascendis Pharma A/S | 14.96B | 0.21% | 475,069 | 1.20B |
| 79 | NBIX | Neurocrine Biosciences, Inc. | 14.48B | 1.25% | 933,282 | 3.37B |
| 80 | EXEL | Exelixis, Inc. | 14.42B | 0.43% | 851,256 | 2.44B |
| 81 | TEM | Tempus AI, Inc. | 13.93B | 0.90% | 3,501,938 | 1.43B |
| 82 | CRL | Charles River Laboratories International, Inc. | 13.78B | 0.67% | 222,281 | 4.00B |
| 83 | SMMT | Summit Therapeutics Inc. | 13.35B | 0.30% | 3,649,976 | - |
| 84 | BBIO | BridgeBio Pharma, Inc. | 13.12B | 0.33% | 1,743,209 | 713.07M |
| 85 | CORT | Corcept Therapeutics Incorporated | 12.57B | 1.97% | 476,829 | 830.81M |
| 86 | PEN | Penumbra, Inc. | 12.53B | - | 126,224 | 1.50B |
| 87 | HALO | Halozyme Therapeutics, Inc. | 12.47B | 2.74% | 1,654,076 | 1.66B |
| 88 | ICLR | ICON Public Limited Company | 12.44B | -0.37% | 402,484 | 8.29B |
| 89 | BTSG | BrightSpring Health Services, Inc. | 12.43B | 4.17% | 1,304,426 | 14.37B |
| 90 | BAX | Baxter International Inc. | 12.13B | -0.78% | 2,398,974 | 11.47B |
| 91 | TXG | 10x Genomics, Inc. | 12.07B | 4.38% | 2,290,176 | 616.91M |
| 92 | FMS | Fresenius Medical Care AG | 11.84B | -0.18% | 332,021 | 22.19B |
| 93 | EHC | Encompass Health Corporation | 11.73B | -0.14% | 592,067 | 6.21B |
| 94 | TWST | Twist Bioscience Corporation | 11.69B | -0.90% | 1,620,607 | 431.80M |
| 95 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.44B | -0.92% | 212,698 | 1.28B |
| 96 | DVA | DaVita Inc. | 11.36B | 1.00% | 222,033 | 14.01B |
| 97 | TECH | Bio-Techne Corporation | 11.36B | 0.02% | 1,294,826 | 1.22B |
| 98 | BMRN | BioMarin Pharmaceutical Inc. | 11.17B | -1.25% | 1,186,382 | 3.41B |
| 99 | ELAN | Elanco Animal Health Incorporated | 11.13B | 2.34% | 2,331,703 | 5.02B |
| 100 | SNN | Smith & Nephew plc | 11.01B | 0.65% | 888,266 | 6.30B |
| 101 | COO | The Cooper Companies, Inc. | 10.92B | 0.07% | 1,826,121 | 4.24B |
| 102 | IBRX | ImmunityBio, Inc. | 10.73B | 9.11% | 24,716,019 | 165.79M |
| 103 | RDY | Dr. Reddy's Laboratories Limited | 10.38B | 0.08% | 2,484,835 | 3.50B |
| 104 | AVTR | Avantor, Inc. | 10.36B | 1.93% | 2,945,531 | 6.56B |
| 105 | ALGN | Align Technology, Inc. | 10.27B | -0.49% | 279,466 | 4.14B |
| 106 | UHS | Universal Health Services, Inc. | 10.26B | -0.54% | 234,331 | 18.11B |
| 107 | RGEN | Repligen Corporation | 10.26B | 2.60% | 894,965 | 785.10M |
| 108 | GMED | Globus Medical, Inc. | 10.18B | 1.92% | 616,829 | 3.14B |
| 109 | ENSG | The Ensign Group, Inc. | 9.94B | 1.44% | 154,460 | 5.49B |
| 110 | BIO | Bio-Rad Laboratories, Inc. | 9.82B | 3.24% | 114,582 | 2.59B |
| 111 | MOH | Molina Healthcare, Inc. | 9.78B | 3.82% | 327,250 | 42.47B |
| 112 | BRKR | Bruker Corporation | 9.72B | 2.99% | 1,287,639 | 3.50B |
| 113 | GKOS | Glaukos Corporation | 9.67B | 0.52% | 365,989 | 612.84M |
| 114 | OSCR | Oscar Health, Inc. | 9.56B | 3.68% | 2,124,863 | 15.32B |
| 115 | KRYS | Krystal Biotech, Inc. | 9.55B | -0.77% | 282,486 | 440.48M |
| 116 | HSIC | Henry Schein, Inc. | 9.44B | -0.22% | 563,828 | 13.60B |
| 117 | AXSM | Axsome Therapeutics, Inc. | 9.40B | -1.44% | 666,551 | 776.57M |
| 118 | QGEN | Qiagen N.V. | 9.33B | 7.37% | 3,680,008 | 2.10B |
| 119 | PODD | Insulet Corporation | 9.14B | 0.72% | 1,013,444 | 3.05B |
| 120 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.08B | -0.74% | 889,738 | 669.50M |
| 121 | CYTK | Cytokinetics, Incorporated | 9.01B | -1.25% | 1,357,477 | 67.67M |
| 122 | PTGX | Protagonist Therapeutics, Inc. | 8.97B | -0.42% | 342,680 | 281.99M |
| 123 | KYMR | Kymera Therapeutics, Inc. | 8.88B | -3.07% | 470,761 | 105.00M |
| 124 | PCVX | Vaxcyte, Inc. | 8.34B | -0.06% | 1,102,235 | - |
| 125 | PRAX | Praxis Precision Medicines, Inc. | 8.28B | 3.36% | 264,945 | 7.46M |
| 126 | ABVX | ABIVAX Société Anonyme | 8.26B | -2.44% | 368,805 | 5.33M |
| 127 | SYRE | Spyre Therapeutics, Inc. | 8.04B | 1.40% | 475,624 | - |
| 128 | CAI | Caris Life Sciences, Inc. | 7.97B | -0.46% | 1,947,061 | 989.61M |
| 129 | HNGE | Hinge Health, Inc. | 7.83B | -0.88% | 557,825 | 720.06M |
| 130 | TGTX | TG Therapeutics, Inc. | 7.69B | 1.04% | 919,041 | 799.54M |
| 131 | ATR | AptarGroup, Inc. | 7.67B | -0.20% | 146,318 | 3.93B |
| 132 | HQY | HealthEquity, Inc. | 7.47B | 1.03% | 449,115 | 1.36B |
| 133 | IONS | Ionis Pharmaceuticals, Inc. | 7.23B | -1.08% | 934,837 | 874.09M |
| 134 | AMRX | Amneal Pharmaceuticals, Inc. | 7.02B | 0.47% | 1,183,548 | 3.12B |
| 135 | ALKS | Alkermes plc | 7.01B | 3.13% | 1,118,867 | 1.67B |
| 136 | IMVT | Immunovant, Inc. | 6.88B | -1.04% | 363,680 | - |
| 137 | PACS | PACS Group, Inc. | 6.73B | 3.53% | 381,736 | 5.55B |
| 138 | HIMS | Hims & Hers Health, Inc. | 6.68B | -2.32% | 7,404,281 | 2.58B |
| 139 | CHE | Chemed Corporation | 6.57B | 0.31% | 68,530 | 2.60B |
| 140 | BLTE | Belite Bio, Inc | 6.53B | -0.55% | 114,434 | - |
| 141 | LNTH | Lantheus Holdings, Inc. | 6.53B | 0.35% | 350,462 | 1.56B |
| 142 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.46B | 0.38% | 230,017 | 239.92M |
| 143 | IOVA | Iovance Biotherapeutics, Inc. | 6.45B | 0.07% | 9,021,915 | 324.97M |
| 144 | GRFS | Grifols, S.A. | 6.45B | 0.14% | 297,143 | 8.48B |
| 145 | GRAL | GRAIL, Inc. | 6.31B | 6.59% | 548,742 | 165.26M |
| 146 | BLCO | Bausch + Lomb Corporation | 6.11B | 1.03% | 214,476 | 5.32B |
| 147 | LGND | Ligand Pharmaceuticals Incorporated | 6.05B | 0.20% | 95,376 | 290.54M |
| 148 | CGON | CG Oncology, Inc. | 5.94B | -1.92% | 937,254 | 6.23M |
| 149 | KNSA | Kiniksa Pharmaceuticals International, plc | 5.91B | 0.74% | 205,231 | 840.85M |
| 150 | KOD | Kodiak Sciences Inc. | 5.86B | -5.17% | 1,970,939 | - |
| 151 | SRRK | Scholar Rock Holding Corporation | 5.73B | 1.84% | 652,943 | - |
| 152 | ORKA | Oruka Therapeutics, Inc. | 5.54B | 0.23% | 279,505 | - |
| 153 | RDNT | RadNet, Inc. | 5.52B | 3.65% | 304,183 | 2.27B |
| 154 | STVN | Stevanato Group S.p.A. | 5.51B | 1.00% | 92,511 | 1.40B |
| 155 | MMED | MiniMed Group, Inc. | 5.51B | -0.05% | 2,516,684 | 3.22B |
| 156 | COGT | Cogent Biosciences, Inc. | 5.37B | -2.15% | 621,449 | - |
| 157 | MIRM | Mirum Pharmaceuticals, Inc. | 5.34B | -1.93% | 695,215 | 618.07M |
| 158 | TVTX | Travere Therapeutics, Inc. | 5.33B | -0.61% | 596,254 | 591.33M |
| 159 | CRSP | CRISPR Therapeutics AG | 5.29B | -1.31% | 755,990 | 13.39M |
| 160 | TFX | Teleflex Incorporated | 5.29B | -1.08% | 333,958 | 2.25B |
| 161 | PTCT | PTC Therapeutics, Inc. | 5.28B | -1.28% | 474,370 | 1.01B |
| 162 | SHC | Sotera Health Company | 5.24B | 1.27% | 801,972 | 1.22B |
| 163 | ERAS | Erasca, Inc. | 5.17B | 1.41% | 2,295,136 | - |
| 164 | MMSI | Merit Medical Systems, Inc. | 5.13B | -0.20% | 196,253 | 1.58B |
| 165 | DOCS | Doximity, Inc. | 5.02B | -1.25% | 1,392,830 | 655.57M |
| 166 | DFTX | Definium Therapeutics, Inc. | 4.98B | -1.38% | 976,868 | - |
| 167 | DNTH | Dianthus Therapeutics, Inc. | 4.95B | 0.17% | 425,257 | 1.90M |
| 168 | BLLN | BillionToOne, Inc. | 4.92B | -1.50% | 278,920 | 397.41M |
| 169 | MANE | Veradermics, Incorporated | 4.86B | -0.78% | 338,517 | - |
| 170 | HAE | Haemonetics Corporation | 4.78B | 0.60% | 149,451 | 1.35B |
| 171 | WAY | Waystar Holding Corp. | 4.76B | -1.97% | 815,816 | 1.21B |
| 172 | CON | Concentra Group Holdings Parent, Inc. | 4.55B | 2.09% | 973,529 | 2.29B |
| 173 | ADPT | Adaptive Biotechnologies Corporation | 4.50B | 2.92% | 892,078 | 308.08M |
| 174 | LFST | LifeStance Health Group, Inc. | 4.49B | -1.30% | 2,355,172 | 1.58B |
| 175 | EWTX | Edgewise Therapeutics, Inc. | 4.49B | 2.15% | 699,423 | - |
| 176 | ABCL | AbCellera Biologics Inc. | 4.45B | -1.19% | 2,780,789 | 66.17M |
| 177 | ITGR | Integer Holdings Corporation | 4.30B | 0.07% | 255,906 | 1.84B |
| 178 | HTFL | HeartFlow, Inc. | 4.30B | 1.08% | 1,192,026 | 212.07M |
| 179 | INDV | Indivior Pharmaceuticals, Inc. | 4.24B | 1.63% | 993,240 | 1.33B |
| 180 | LIVN | LivaNova PLC | 4.17B | 1.40% | 273,037 | 1.47B |
| 181 | RLAY | Relay Therapeutics, Inc. | 4.11B | 1.46% | 1,464,911 | 10.35M |
| 182 | ICUI | ICU Medical, Inc. | 4.02B | 2.16% | 110,603 | 2.16B |
| 183 | TNGX | Tango Therapeutics, Inc. | 3.94B | -4.46% | 3,190,946 | 53.81M |
| 184 | NVST | Envista Holdings Corporation | 3.78B | 1.73% | 1,226,551 | 2.86B |
| 185 | VCYT | Veracyte, Inc. | 3.66B | 3.10% | 467,915 | 561.90M |
| 186 | PBLS | Parabilis Medicines, Inc. | 3.66B | -2.73% | 557,731 | 148.00K |
| 187 | IRTC | iRhythm Holdings, Inc. | 3.64B | -0.55% | 193,112 | 825.34M |
| 188 | XENE | Xenon Pharmaceuticals Inc. | 3.64B | -3.54% | 1,168,499 | 7.50M |
| 189 | OGN | Organon & Co. | 3.60B | 0.11% | 1,151,837 | 6.13B |
| 190 | LEGN | Legend Biotech Corporation | 3.60B | -3.78% | 1,715,672 | 1.27B |
| 191 | TLX | Telix Pharmaceuticals Limited | 3.58B | -1.77% | 254,548 | 890.79M |
| 192 | IDYA | IDEAYA Biosciences, Inc. | 3.58B | -1.93% | 288,586 | 234.13M |
| 193 | NHC | National HealthCare Corporation | 3.55B | 1.58% | 56,673 | 1.56B |
| 194 | RGC | Regencell Bioscience Holdings Limited | 3.51B | 12.01% | 372,821 | - |
| 195 | VKTX | Viking Therapeutics, Inc. | 3.49B | -1.84% | 4,407,676 | - |
| 196 | CDNA | CareDx, Inc. | 3.49B | 1.74% | 1,058,047 | 458.09M |
| 197 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.48B | -1.12% | 522,316 | -665.00K |
| 198 | CELC | Celcuity Inc. | 3.48B | -5.30% | 652,154 | - |
| 199 | PLSE | Pulse Biosciences, Inc. | 3.47B | -2.31% | 226,175 | 1.19M |
| 200 | ACAD | Acadia Pharmaceuticals Inc. | 3.47B | 1.26% | 1,525,098 | 1.14B |
| 201 | OPCH | Option Care Health, Inc. | 3.40B | 0.62% | 526,000 | 5.69B |
| 202 | ELVN | Enliven Therapeutics, Inc. | 3.37B | -0.35% | 392,176 | - |
| 203 | WRBY | Warby Parker Inc. | 3.37B | -0.91% | 1,839,822 | 911.61M |
| 204 | TARS | Tarsus Pharmaceuticals, Inc. | 3.22B | -2.85% | 368,245 | 606.33M |
| 205 | DNLI | Denali Therapeutics Inc. | 3.20B | -2.63% | 986,254 | 3.60M |
| 206 | ARQT | Arcutis Biotherapeutics, Inc. | 3.16B | -0.43% | 1,013,232 | 463.98M |
| 207 | RCUS | Arcus Biosciences, Inc. | 3.08B | -4.00% | 475,384 | 117.00M |
| 208 | PGEN | Precigen, Inc. | 3.02B | 2.80% | 4,802,746 | 85.72M |
| 209 | DYN | Dyne Therapeutics, Inc. | 2.84B | -3.79% | 1,123,176 | - |
| 210 | MBX | MBX Biosciences, Inc. | 2.81B | 3.08% | 374,599 | - |
| 211 | ATRC | AtriCure, Inc. | 2.79B | 2.27% | 1,003,503 | 569.62M |
| 212 | AVAH | Aveanna Healthcare Holdings Inc. | 2.74B | 1.13% | 1,203,994 | 2.60B |
| 213 | TMDX | TransMedics Group, Inc. | 2.73B | 0.03% | 833,088 | 668.47M |
| 214 | NAMS | NewAmsterdam Pharma Company N.V. | 2.73B | -5.63% | 821,208 | 7.12M |
| 215 | ZLAB | Zai Lab Limited | 2.71B | -5.37% | 570,101 | 449.61M |
| 216 | NEOG | Neogen Corporation | 2.69B | 0.94% | 1,313,525 | 870.40M |
| 217 | GRDN | Guardian Pharmacy Services, Inc. | 2.64B | 2.14% | 235,894 | 1.46B |
| 218 | BKD | Brookdale Senior Living Inc. | 2.59B | -0.09% | 4,008,546 | 2.93B |
| 219 | PRVA | Privia Health Group, Inc. | 2.58B | 0.90% | 622,375 | 2.36B |
| 220 | ACHC | Acadia Healthcare Company, Inc. | 2.58B | 2.90% | 803,415 | 3.37B |
| 221 | SUPN | Supernus Pharmaceuticals, Inc. | 2.48B | 1.00% | 478,561 | 830.44M |
| 222 | HCM | HUTCHMED (China) Limited | 2.47B | -2.06% | 32,041 | 549.12M |
| 223 | LQDA | Liquidia Corporation | 2.47B | -1.46% | 5,537,396 | 450.91M |
| 224 | IRON | Disc Medicine, Inc. | 2.47B | 1.07% | 391,547 | - |
| 225 | CLDX | Celldex Therapeutics, Inc. | 2.46B | -2.58% | 1,398,099 | 158.00K |
| 226 | BEAM | Beam Therapeutics Inc. | 2.42B | -0.66% | 934,120 | 156.04M |
| 227 | IMNM | Immunome, Inc. | 2.38B | 0.36% | 691,522 | 4.02M |
| 228 | NRIX | Nurix Therapeutics, Inc. | 2.37B | -1.97% | 378,650 | 36.77M |
| 229 | ALMR | Alamar Biosciences, Inc. | 2.37B | 5.08% | 129,620 | 100.42M |
| 230 | BFLY | Butterfly Network, Inc. | 2.36B | 3.69% | 2,844,420 | 112.14M |
| 231 | NEO | NeoGenomics, Inc. | 2.35B | 3.09% | 1,312,374 | 766.30M |
| 232 | UFPT | UFP Technologies, Inc. | 2.34B | 2.52% | 86,230 | 631.64M |
| 233 | SLS | SELLAS Life Sciences Group, Inc. | 2.33B | 1.77% | 2,645,055 | - |
| 234 | CLOV | Clover Health Investments, Corp. | 2.33B | 3.55% | 2,198,093 | 2.48B |
| 235 | HRMY | Harmony Biosciences Holdings, Inc. | 2.30B | -0.03% | 488,392 | 959.90M |
| 236 | SDGR | Schrödinger, Inc. | 2.29B | 0.57% | 2,348,590 | 259.04M |
| 237 | AXGN | Axogen, Inc. | 2.21B | -5.69% | 2,055,552 | 251.17M |
| 238 | ADMA | ADMA Biologics, Inc. | 2.20B | -1.26% | 1,506,469 | 512.28M |
| 239 | VRDN | Viridian Therapeutics, Inc. | 2.19B | 1.87% | 837,399 | 71.13M |
| 240 | RXRX | Recursion Pharmaceuticals, Inc. | 2.18B | -0.12% | 14,269,271 | 54.86M |
| 241 | PHVS | Pharvaris N.V. | 2.18B | 0.13% | 407,289 | - |
| 242 | WGS | GeneDx Holdings Corp. | 2.16B | 2.23% | 306,366 | 454.43M |
| 243 | VERA | Vera Therapeutics, Inc. | 2.16B | -3.36% | 1,103,273 | - |
| 244 | PBH | Prestige Consumer Healthcare Inc. | 2.15B | 1.53% | 211,342 | 1.10B |
| 245 | BHC | Bausch Health Companies Inc. | 2.15B | 0.26% | 2,412,689 | 10.85B |
| 246 | AUPH | Aurinia Pharmaceuticals Inc. | 2.10B | -0.97% | 460,501 | 311.51M |
| 247 | MLYS | Mineralys Therapeutics, Inc. | 2.09B | -0.13% | 554,411 | - |
| 248 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.08B | 0.25% | 4,031,404 | 940.61M |
| 249 | INSP | Inspire Medical Systems, Inc. | 2.05B | - | 394,769 | 898.74M |
| 250 | MD | Pediatrix Medical Group, Inc. | 2.04B | 0.08% | 237,179 | 1.95B |
| 251 | ADUS | Addus HomeCare Corporation | 2.04B | 0.04% | 100,802 | 1.48B |
| 252 | TRLV | Trulieve Cannabis Corp. | 2.04B | -2.53% | 1,727,683 | 1.14B |
| 253 | MRVI | Maravai LifeSciences Holdings, Inc. | 2.04B | 4.73% | 1,076,530 | 208.78M |
| 254 | VCEL | Vericel Corporation | 2.04B | 0.99% | 269,600 | 306.30M |
| 255 | ADRX | ADARx Pharmaceuticals, Inc. | 2.04B | -7.01% | 559,062 | 6.13M |
| 256 | URGN | UroGen Pharma Ltd. | 2.01B | 1.18% | 381,074 | 188.73M |
| 257 | GPCR | Structure Therapeutics Inc. | 1.99B | -3.55% | 897,559 | - |
| 258 | PRGO | Perrigo Company plc | 1.99B | 2.32% | 1,035,739 | 4.14B |
| 259 | TRVI | Trevi Therapeutics, Inc. | 1.97B | -2.26% | 1,071,406 | - |
| 260 | ALVO | Alvotech | 1.95B | -3.02% | 496,334 | 494.61M |
| 261 | PGNY | Progyny, Inc. | 1.94B | 1.99% | 397,202 | 1.31B |
| 262 | BHVN | Biohaven Ltd. | 1.92B | -3.50% | 1,036,017 | - |
| 263 | AGIO | Agios Pharmaceuticals, Inc. | 1.90B | -1.85% | 315,504 | 98.34M |
| 264 | ABSI | Absci Corporation | 1.90B | 2.98% | 2,402,449 | 1.56M |
| 265 | ESTA | Establishment Labs Holdings Inc. | 1.90B | 1.03% | 168,371 | 245.82M |
| 266 | FTRE | Fortrea Holdings Inc. | 1.88B | 2.04% | 471,149 | 2.68B |
| 267 | LKFT | Lakefront Biotherapeutics NV | 1.88B | 0.68% | 160,705 | 1.13B |
| 268 | VIR | Vir Biotechnology, Inc. | 1.88B | -1.64% | 1,413,649 | 303.23M |
| 269 | PVLA | Palvella Therapeutics, Inc. | 1.87B | -2.09% | 165,766 | - |
| 270 | ZBIO | Zenas BioPharma, Inc. | 1.87B | 2.43% | 1,440,309 | 1.00M |
| 271 | MESO | Mesoblast Limited | 1.84B | -1.68% | 189,190 | 120.25M |
| 272 | ASTH | Astrana Health, Inc. | 1.84B | 2.84% | 160,588 | 3.84B |
| 273 | SRPT | Sarepta Therapeutics, Inc. | 1.83B | -1.62% | 1,080,111 | 1.97B |
| 274 | BLFS | BioLife Solutions, Inc. | 1.82B | 1.41% | 2,159,525 | 106.69M |
| 275 | XNCR | Xencor, Inc. | 1.81B | -1.61% | 470,979 | 104.97M |
| 276 | LMAT | LeMaitre Vascular, Inc. | 1.80B | -1.70% | 217,355 | 262.43M |
| 277 | SNDA | Sonida Senior Living, Inc. | 1.80B | 0.48% | 321,025 | 481.07M |
| 278 | NUVB | Nuvation Bio Inc. | 1.79B | -8.27% | 10,568,115 | 169.90M |
| 279 | ZYME | Zymeworks Inc. | 1.78B | -3.16% | 364,703 | 37.13M |
| 280 | NVCR | NovoCure Limited | 1.77B | -4.52% | 912,105 | 699.19M |
| 281 | SEPN | Septerna, Inc. | 1.76B | -0.74% | 192,740 | 98.88M |
| 282 | BRVE | Braveheart Bio, Inc. | 1.76B | -0.51% | 262,926 | - |
| 283 | PSNL | Personalis, Inc. | 1.73B | 0.12% | 741,791 | 69.67M |
| 284 | XRAY | DENTSPLY SIRONA Inc. | 1.73B | -0.97% | 3,400,978 | 3.64B |
| 285 | SGRY | Surgery Partners, Inc. | 1.72B | 0.42% | 531,754 | 3.37B |
| 286 | GENB | Generate Biomedicines, Inc. | 1.72B | -3.04% | 855,406 | 26.48M |
| 287 | NTLA | Intellia Therapeutics, Inc. | 1.71B | 0.83% | 3,313,233 | 59.51M |
| 288 | FRNM | Freenome, Inc. | 1.71B | 1.82% | 490,327 | 35.41M |
| 289 | NVAX | Novavax, Inc. | 1.71B | -2.31% | 2,586,775 | 413.80M |
| 290 | AZTA | Azenta, Inc. | 1.69B | 11.57% | 2,629,731 | 613.81M |
| 291 | XERS | Xeris Biopharma Holdings, Inc. | 1.67B | -1.03% | 809,208 | 335.41M |
| 292 | CMPS | COMPASS Pathways plc | 1.65B | -0.42% | 1,636,568 | - |
| 293 | STOK | Stoke Therapeutics, Inc. | 1.64B | -2.13% | 381,609 | 27.59M |
| 294 | ALHC | Alignment Healthcare, Inc. | 1.64B | 2.20% | 3,435,822 | 4.58B |
| 295 | KMTS | Kestra Medical Technologies, Ltd. | 1.63B | 0.89% | 104,108 | 106.73M |
| 296 | QURE | uniQure N.V. | 1.62B | -0.19% | 1,325,104 | 18.67M |
| 297 | SNDX | Syndax Pharmaceuticals, Inc. | 1.58B | -3.18% | 992,663 | 252.25M |
| 298 | GHRS | GH Research PLC | 1.57B | - | 162,545 | - |
| 299 | ETON | Eton Pharmaceuticals, Inc. | 1.57B | 5.56% | 417,650 | 105.60M |
| 300 | ANIP | ANI Pharmaceuticals, Inc. | 1.54B | -1.30% | 141,197 | 978.38M |
| 301 | OMCL | Omnicell, Inc. | 1.54B | 0.87% | 148,086 | 1.25B |
| 302 | OCUL | Ocular Therapeutix, Inc. | 1.54B | -4.05% | 3,542,886 | 52.06M |
| 303 | ATEC | Alphatec Holdings, Inc. | 1.53B | 0.15% | 1,229,092 | 815.05M |
| 304 | RAPP | Rapport Therapeutics, Inc. | 1.53B | -2.80% | 123,430 | 20.00M |
| 305 | TSHA | Taysha Gene Therapies, Inc. | 1.52B | -1.58% | 1,455,189 | 5.49M |
| 306 | IMCR | Immunocore Holdings plc | 1.52B | -3.42% | 372,164 | 430.78M |
| 307 | PAHC | Phibro Animal Health Corporation | 1.52B | 4.27% | 116,899 | 1.52B |
| 308 | NKTR | Nektar Therapeutics | 1.50B | -6.77% | 2,140,253 | 54.59M |
| 309 | INVA | Innoviva, Inc. | 1.49B | 0.54% | 418,282 | 440.00M |
| 310 | RARE | Ultragenyx Pharmaceutical Inc. | 1.49B | 2.88% | 2,115,616 | 717.00M |
| 311 | NUTX | Nutex Health Inc. | 1.49B | 2.21% | 245,459 | 846.72M |
| 312 | MAZE | Maze Therapeutics, Inc. | 1.47B | -0.79% | 386,097 | 20.00M |
| 313 | ANAB | AnaptysBio, Inc. | 1.46B | 0.53% | 290,855 | 106.09M |
| 314 | ARDT | Ardent Health, Inc. | 1.46B | 0.88% | 140,625 | 6.41B |
| 315 | NBTX | Nanobiotix S.A. | 1.45B | -7.60% | 206,169 | 13.15M |
| 316 | COAG | Hemab Therapeutics Holdings, Inc. | 1.44B | -1.03% | 200,976 | - |
| 317 | INBX | Inhibrx Biosciences, Inc. | 1.44B | -0.39% | 89,772 | 1.30M |
| 318 | HCSG | Healthcare Services Group, Inc. | 1.43B | 1.21% | 273,699 | 1.86B |
| 319 | AGL | agilon health, inc. | 1.42B | 3.11% | 111,621 | 5.92B |
| 320 | AMN | AMN Healthcare Services, Inc. | 1.42B | 2.45% | 313,944 | 3.43B |
| 321 | CERT | Certara, Inc. | 1.42B | -0.64% | 1,302,609 | 421.75M |
| 322 | KARD | Kardigan, Inc. | 1.41B | 5.54% | 289,788 | - |
| 323 | TYRA | Tyra Biosciences, Inc. | 1.40B | -2.95% | 568,279 | - |
| 324 | CNMD | CONMED Corporation | 1.40B | 1.65% | 129,397 | 1.37B |
| 325 | AVBP | ArriVent BioPharma, Inc. | 1.38B | -3.18% | 242,357 | - |
| 326 | AAPG | Ascentage Pharma Group International | 1.37B | -5.66% | 3,463 | 94.61M |
| 327 | KLRA | Kailera Therapeutics, Inc. | 1.37B | -4.35% | 656,054 | - |
| 328 | PNTG | The Pennant Group, Inc. | 1.37B | 0.93% | 136,225 | 1.10B |
| 329 | DRTS | Alpha Tau Medical Ltd. | 1.36B | 1.24% | 188,758 | - |
| 330 | KRSA | Korsana Biosciences, Inc. | 1.35B | -4.65% | 37,402 | - |
| 331 | OMER | Omeros Corporation | 1.33B | -0.54% | 525,098 | 38.42M |
| 332 | OMDA | Omada Health, Inc. | 1.26B | 1.18% | 690,293 | 309.76M |
| 333 | ORIC | ORIC Pharmaceuticals, Inc. | 1.26B | -2.64% | 577,310 | - |
| 334 | USPH | U.S. Physical Therapy, Inc. | 1.25B | 1.27% | 155,773 | 804.27M |
| 335 | DMRA | Damora Therapeutics, Inc. | 1.25B | -0.15% | 461,140 | - |
| 336 | AVLN | Avalyn Pharma Inc. | 1.25B | 2.52% | 328,388 | - |
| 337 | REPL | Replimune Group, Inc. | 1.23B | -2.57% | 750,183 | - |
| 338 | INNV | InnovAge Holding Corp. | 1.23B | 2.16% | 194,600 | 989.71M |
| 339 | SVRA | Savara Inc. | 1.21B | -5.35% | 1,758,975 | - |
| 340 | MNKD | MannKind Corporation | 1.20B | -5.44% | 2,962,392 | 393.63M |
| 341 | LBRX | LB Pharmaceuticals Inc | 1.19B | -0.80% | 251,544 | - |
| 342 | CRON | Cronos Group Inc. | 1.18B | 0.78% | 1,017,526 | 179.09M |
| 343 | TRAX | First Tracks Biotherapeutics, Inc. | 1.18B | -3.04% | 681,188 | - |
| 344 | OPK | OPKO Health, Inc. | 1.17B | -0.32% | 919,701 | 587.90M |
| 345 | BCAX | Bicara Therapeutics Inc. | 1.17B | -3.13% | 357,268 | - |
| 346 | TNDM | Tandem Diabetes Care, Inc. | 1.15B | -0.18% | 1,616,203 | 1.04B |
| 347 | HROW | Harrow, Inc. | 1.14B | -0.72% | 260,452 | 275.59M |
| 348 | STAA | STAAR Surgical Company | 1.13B | 0.63% | 301,729 | 339.59M |
| 349 | GDRX | GoodRx Holdings, Inc. | 1.13B | 0.92% | 358,649 | 785.23M |
| 350 | BVS | Bioventus Inc. | 1.11B | -2.08% | 204,885 | 581.85M |
| 351 | IRMD | IRADIMED CORPORATION | 1.09B | 0.34% | 73,719 | 86.34M |
| 352 | AORT | Artivion, Inc. | 1.09B | 2.05% | 267,557 | 471.47M |
| 353 | CSTL | Castle Biosciences, Inc. | 1.08B | 0.52% | 81,408 | 357.28M |
| 354 | VOR | Vor Biopharma Inc. | 1.08B | 1.33% | 448,075 | - |
| 355 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.08B | 0.32% | 151,085 | 730.02M |
| 356 | LTGO | Latigo Biotherapeutics, Inc. | 1.05B | -5.33% | 124,217 | - |
| 357 | IMTX | Immatics N.V. | 1.04B | -9.60% | 694,811 | 47.65M |
| 358 | MGTX | MeiraGTx Holdings plc | 1.04B | 1.83% | 469,282 | 397.50M |
| 359 | JANX | Janux Therapeutics, Inc. | 1.04B | -0.12% | 488,189 | 24.00M |
| 360 | ENOV | Enovis Corporation | 1.03B | -0.89% | 738,576 | 2.30B |
| 361 | AKTS | Aktis Oncology, Inc. | 1.02B | -1.21% | 213,474 | 10.06M |
| 362 | IART | Integra LifeSciences Holdings Corporation | 1.01B | -18.89% | 1,992,230 | 1.65B |
| 363 | TDOC | Teladoc Health, Inc. | 1.00B | -2.47% | 2,462,416 | 2.49B |
| 364 | PCRX | Pacira BioSciences, Inc. | 1.00B | 0.52% | 277,238 | 746.16M |
| 365 | LMRI | Lumexa Imaging Holdings, Inc. | 994.38M | 2.48% | 264,041 | 1.04B |
| 366 | ODTX | Odyssey Therapeutics, Inc. | 991.91M | 1.37% | 114,807 | 99.00K |
| 367 | PRCT | PROCEPT BioRobotics Corporation | 982.82M | 0.82% | 677,341 | 337.34M |
| 368 | BBNX | Beta Bionics, Inc. | 980.72M | -1.27% | 285,799 | 119.01M |
| 369 | SPTX | Seaport Therapeutics, Inc. | 976.40M | -3.75% | 93,781 | - |
| 370 | ANL | Adlai Nortye Group Ltd. | 975.31M | -3.90% | 56,821 | 18.06M |
| 371 | MLTX | MoonLake Immunotherapeutics | 963.41M | -1.31% | 1,347,639 | - |
| 372 | CGEM | Cullinan Therapeutics, Inc. | 962.75M | 2.96% | 726,756 | - |
| 373 | KURA | Kura Oncology, Inc. | 950.99M | 0.38% | 1,081,447 | 77.23M |
| 374 | ANRO | Alto Neuroscience, Inc. | 940.24M | -5.33% | 314,989 | - |
| 375 | HSTM | HealthStream, Inc. | 939.60M | 1.15% | 77,249 | 321.12M |
| 376 | AHG | Akso Health Group | 916.67M | 4.90% | 67,799 | 13.83M |
| 377 | APMD | Apnimed, Inc. | 907.97M | -3.24% | 327,750 | 115.12M |
| 378 | CRVS | Corvus Pharmaceuticals, Inc. | 905.98M | -1.46% | 809,161 | - |
| 379 | CBLL | CeriBell, Inc. | 896.13M | -1.10% | 170,002 | 101.96M |
| 380 | SLBT | SL Science Holding Limited | 895.32M | -1.88% | 46,855 | 3.27M |
| 381 | JBIO | Jade Biosciences, Inc. | 885.91M | 1.16% | 787,382 | - |
| 382 | GLUE | Monte Rosa Therapeutics, Inc. | 884.70M | -7.90% | 1,140,308 | 28.73M |
| 383 | ALMS | Alumis Inc. | 880.81M | -5.62% | 1,238,736 | 7.40M |
| 384 | ABUS | Arbutus Biopharma Corporation | 872.51M | -3.29% | 6,267,633 | 181.72M |
| 385 | RIGL | Rigel Pharmaceuticals, Inc. | 868.61M | -1.00% | 80,307 | 276.79M |
| 386 | SANA | Sana Biotechnology, Inc. | 857.67M | -0.87% | 2,279,747 | - |
| 387 | SGP | SpyGlass Pharma, Inc. | 850.92M | -4.00% | 101,323 | - |
| 388 | HELP | Helus Pharma Inc. | 847.50M | -2.60% | 899,436 | - |
| 389 | ARDX | Ardelyx, Inc. | 833.53M | -1.04% | 2,710,941 | 450.89M |
| 390 | OBX | Obsidian Therapeutics, Inc. | 826.52M | 0.45% | 83,173 | - |
| 391 | DNA | Ginkgo Bioworks Holdings, Inc. | 822.90M | -2.24% | 1,450,132 | 132.42M |
| 392 | LXRX | Lexicon Pharmaceuticals, Inc. | 816.49M | 0.82% | 1,339,295 | 41.47M |
| 393 | IVA | Inventiva S.A. | 810.04M | 3.18% | 3,238,038 | 2.81M |
| 394 | INMD | InMode Ltd. | 809.04M | 0.18% | 372,602 | 374.63M |
| 395 | SIBN | SI-BONE, Inc. | 808.08M | -2.06% | 299,353 | 213.60M |
| 396 | PACB | Pacific Biosciences of California, Inc. | 795.73M | 1.99% | 19,561,536 | 159.27M |
| 397 | IMMX | Immix Biopharma, Inc. | 790.07M | -6.84% | 1,320,760 | - |
| 398 | ANNX | Annexon, Inc. | 789.60M | 1.09% | 2,693,356 | - |
| 399 | AVTX | Avalo Therapeutics, Inc. | 785.14M | -2.07% | 436,106 | 59.00K |
| 400 | ATTO | Attovia Therapeutics, Inc. | 782.92M | -3.60% | 208,789 | 1.80M |
| 401 | GERN | Geron Corporation | 780.61M | 0.41% | 6,712,892 | 204.56M |
| 402 | VREX | Varex Imaging Corporation | 779.32M | - | 275,864 | 865.00M |
| 403 | DSGN | Design Therapeutics, Inc. | 773.82M | 1.02% | 318,629 | - |
| 404 | CADL | Candel Therapeutics, Inc. | 773.22M | -0.54% | 511,728 | - |
| 405 | AVR | Anteris Technologies Global Corp. | 762.13M | 2.76% | 609,859 | 2.24M |
| 406 | GYRE | Gyre Therapeutics, Inc. | 761.32M | 2.57% | 115,372 | 109.82M |
| 407 | CTKB | Cytek Biosciences, Inc. | 761.05M | 0.77% | 596,655 | 206.71M |
| 408 | FDMT | 4D Molecular Therapeutics, Inc. | 757.40M | -0.94% | 637,483 | 92.01M |
| 409 | GMRS | GMR Solutions Inc. | 756.23M | 3.29% | 700,556 | 5.88B |
| 410 | AHCO | AdaptHealth Corp. | 753.76M | -0.53% | 892,472 | 3.36B |
| 411 | WVE | Wave Life Sciences, Inc. | 746.81M | -2.32% | 2,269,796 | 65.37M |
| 412 | QDEL | QuidelOrtho Corporation | 740.61M | 4.05% | 1,307,469 | 2.67B |
| 413 | ACHV | Achieve Life Sciences, Inc. | 733.18M | -5.38% | 911,185 | - |
| 414 | SLDB | Solid Biosciences Inc. | 730.20M | -2.44% | 599,097 | - |
| 415 | FTH | Faeth Therapeutics, Inc. | 724.82M | -0.78% | 105,514 | - |
| 416 | COLL | Collegium Pharmaceutical, Inc. | 716.22M | 0.73% | 362,919 | 808.21M |
| 417 | OABI | OmniAb, Inc. | 714.59M | -1.50% | 1,206,166 | 38.46M |
| 418 | OLMA | Olema Pharmaceuticals, Inc. | 713.11M | -1.45% | 577,282 | - |
| 419 | PHAR | Pharming Group N.V. | 705.87M | -1.71% | 11,340 | 366.48M |
| 420 | NVCT | Nuvectis Pharma, Inc. | 703.44M | 4.20% | 107,811 | - |
| 421 | SOPH | SOPHiA GENETICS SA | 683.58M | - | 595,222 | 86.17M |
| 422 | VSTM | Verastem, Inc. | 681.94M | -4.68% | 2,707,863 | 87.53M |
| 423 | MDXG | MiMedx Group, Inc. | 671.96M | -0.65% | 817,904 | 355.17M |
| 424 | STTK | Shattuck Labs, Inc. | 663.40M | -3.36% | 1,242,711 | 1.00M |
| 425 | DBVT | DBV Technologies S.A. | 653.00M | -5.53% | 579,546 | 5.04M |
| 426 | ETRA | Electra Therapeutics, Inc. | 646.50M | -3.56% | 206,774 | - |
| 427 | STLN | Starling Oncology, Inc. | 645.13M | 1.85% | 517,026 | 587.24M |
| 428 | SGMT | Sagimet Biosciences Inc. | 639.95M | -3.68% | 1,095,590 | - |
| 429 | SLN | Silence Therapeutics plc | 637.01M | -1.21% | 504,146 | 615.00K |
| 430 | PHR | Phreesia, Inc. | 629.40M | -2.12% | 208,435 | 507.79M |
| 431 | ANGO | AngioDynamics, Inc. | 629.08M | 0.66% | 447,619 | 320.17M |
| 432 | ACRS | Aclaris Therapeutics, Inc. | 622.65M | -4.08% | 4,220,295 | 8.22M |
| 433 | AURA | Aura Biosciences, Inc. | 622.23M | -0.66% | 1,552,885 | - |
| 434 | CLYM | Climb Bio, Inc. | 620.31M | -2.44% | 976,636 | - |
| 435 | CBIO | Crescent Biopharma, Inc. | 614.20M | 0.63% | 87,785 | 11.88M |
| 436 | BLSM | BlossomHill Therapeutics, Inc. | 607.09M | 2.74% | 72,473 | - |
| 437 | EVO | Evotec SE | 605.97M | -3.34% | 18,268 | 819.47M |
| 438 | IRWD | Ironwood Pharmaceuticals, Inc. | 598.99M | -3.59% | 1,996,457 | 389.32M |
| 439 | ZVRA | Zevra Therapeutics, Inc. | 592.65M | -1.96% | 627,680 | 136.07M |
| 440 | WEAV | Weave Communications, Inc. | 589.99M | -0.07% | 481,421 | 257.79M |
| 441 | FLGT | Fulgent Genetics, Inc. | 589.65M | 0.61% | 151,915 | 323.93M |
| 442 | KIDS | OrthoPediatrics Corp. | 577.55M | 1.98% | 82,154 | 252.72M |
| 443 | YDES | YD Bio Limited | 571.61M | 3.33% | 486,618 | 1.24M |
| 444 | AQST | Aquestive Therapeutics, Inc. | 567.31M | 1.80% | 1,429,087 | 54.09M |
| 445 | CRMD | CorMedix Inc. | 561.20M | -2.96% | 756,621 | 462.25M |
| 446 | CTMX | CytomX Therapeutics, Inc. | 561.09M | -2.09% | 1,546,449 | 18.30M |
| 447 | MPLT | MapLight Therapeutics, Inc. | 554.09M | 3.53% | 389,016 | - |
| 448 | PHAT | Phathom Pharmaceuticals, Inc. | 551.24M | -1.98% | 1,006,200 | 239.66M |
| 449 | SSII | SS Innovations International, Inc. | 546.05M | -0.91% | 36,856 | 52.40M |
| 450 | VALN | Valneva SE | 540.23M | -0.75% | 37,449 | 163.30M |
| 451 | OCS | Oculis Holding AG | 533.06M | -1.43% | 326,255 | 1.45M |
| 452 | ALT | Altimmune, Inc. | 531.03M | -1.09% | 2,898,840 | 31.00K |
| 453 | PRME | Prime Medicine, Inc. | 526.60M | -1.00% | 1,555,258 | 4.07M |
| 454 | SENS | Senseonics Holdings, Inc. | 524.51M | -0.40% | 450,636 | 48.55M |
| 455 | DCTH | Delcath Systems, Inc. | 523.60M | -2.08% | 255,584 | 95.42M |
| 456 | MASS | 908 Devices Inc. | 522.25M | 1.00% | 239,601 | 60.84M |
| 457 | ALLO | Allogene Therapeutics, Inc. | 519.96M | -2.27% | 3,309,479 | 4.64M |
| 458 | CAPR | Capricor Therapeutics, Inc. | 519.76M | - | 1,889,645 | 11.13M |
| 459 | MNPR | Monopar Therapeutics Inc. | 519.19M | -0.80% | 61,324 | - |
| 460 | EPRX | Eupraxia Pharmaceuticals Inc. | 517.54M | -5.36% | 1,007,565 | - |
| 461 | PROK | ProKidney Corp. | 513.95M | -0.58% | 614,419 | 818.00K |
| 462 | GLAS | Glass House Brands Inc. | 507.97M | 1.32% | 1,111,094 | 176.98M |
| 463 | BWAY | BrainsWay Ltd. | 506.80M | -0.95% | 35,568 | 60.70M |
| 464 | TCMD | Tactile Systems Technology, Inc. | 506.51M | 2.99% | 154,140 | 350.31M |
| 465 | NGNE | Neurogene Inc. | 506.39M | -4.69% | 238,892 | 925.00K |
| 466 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 4.81M |
| 467 | TLRY | Tilray Brands, Inc. | 495.22M | 1.26% | 3,008,703 | 915.45M |
| 468 | ENTX | Entera Bio Ltd. | 495.19M | -1.04% | 54,487 | 42.00K |
| 469 | PBYI | Puma Biotechnology, Inc. | 494.52M | -2.64% | 225,946 | 231.24M |
| 470 | RGNX | REGENXBIO Inc. | 494.44M | 0.94% | 482,645 | 174.48M |
| 471 | DRUG | Bright Minds Biosciences Inc. | 491.05M | -0.43% | 76,105 | - |
| 472 | CTNM | Contineum Therapeutics, Inc. | 486.07M | -0.54% | 385,790 | - |
| 473 | ARVN | Arvinas, Inc. | 481.90M | -0.81% | 267,699 | 316.70M |
| 474 | TKNO | Alpha Teknova, Inc. | 480.78M | 1.07% | 167,174 | 43.70M |
| 475 | EOLS | Evolus, Inc. | 475.56M | -6.37% | 1,646,864 | 316.49M |
| 476 | KMDA | Kamada Ltd. | 475.28M | 0.37% | 35,210 | 191.85M |
| 477 | SGHT | Sight Sciences, Inc. | 474.31M | -4.65% | 290,842 | 83.38M |
| 478 | AUTL | Autolus Therapeutics plc | 469.78M | -4.59% | 1,411,685 | 117.39M |
| 479 | OVID | Ovid Therapeutics Inc. | 459.93M | -3.09% | 951,216 | 1.58M |
| 480 | CERS | Cerus Corporation | 459.48M | -1.72% | 1,087,344 | 221.55M |
| 481 | NRC | NRC Health | 453.67M | -3.80% | 60,370 | 140.00M |
| 482 | ASMB | Assembly Biosciences, Inc. | 449.77M | -3.87% | 210,746 | 74.85M |
| 483 | TECX | Tectonic Therapeutic, Inc. | 443.77M | 0.13% | 133,303 | - |
| 484 | NPCE | NeuroPace, Inc. | 438.32M | -2.89% | 69,264 | 106.99M |
| 485 | DMAC | DiaMedica Therapeutics Inc. | 436.80M | -2.99% | 244,496 | - |
| 486 | PRTA | Prothena Corporation plc | 433.28M | -1.17% | 399,539 | 54.53M |
| 487 | MYGN | Myriad Genetics, Inc. | 426.60M | 9.85% | 1,222,707 | 806.60M |
| 488 | SRTA | Strata Critical Medical, Inc. | 423.31M | -0.93% | 502,579 | 255.98M |
| 489 | RZLT | Rezolute, Inc. | 421.69M | -1.23% | 664,525 | - |
| 490 | SPRY | ARS Pharmaceuticals, Inc. | 410.72M | 0.24% | 1,042,413 | 116.93M |
| 491 | AGMB | AgomAb Therapeutics NV | 409.74M | -3.82% | 271,132 | - |
| 492 | AVIR | Atea Pharmaceuticals, Inc. | 407.44M | -0.39% | 120,945 | - |
| 493 | EDIT | Editas Medicine, Inc. | 395.47M | 2.18% | 1,271,019 | 47.01M |
| 494 | GALT | Galectin Therapeutics Inc. | 395.33M | 4.26% | 98,638 | - |
| 495 | EVH | Evolent Health, Inc. | 394.58M | 2.95% | 1,167,498 | 2.10B |
| 496 | ZURA | Zura Bio Limited | 393.86M | -0.72% | 2,182,183 | - |
| 497 | CARL | Carlsmed, Inc. | 393.16M | 4.65% | 123,001 | 63.30M |
| 498 | RCEL | AVITA Medical, Inc. | 392.15M | 5.58% | 254,640 | 75.63M |
| 499 | SI | Shoulder Innovations, Inc. | 392.02M | 0.43% | 82,643 | 60.06M |
| 500 | EIKN | Eikon Therapeutics, Inc. | 389.18M | -3.04% | 290,084 | - |